N-[4-(5-Nitro-2-Furyl)-2-Thiazolyl]Acetamide (IARC Summary & Evaluation, Volume 1, 1972)

International Agency for Research on Cancer (IARC) - Summaries & Evaluations

N-[4-(5-NITRO-2-FURYL)-2-THIAZOLYL]ACETAMIDE

VOL.: 1 (1972) (p. 181)

5. Summary of Data Reported and Evaluation

5.1 Animal carcinogenicity data

N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide (NFTA) given orally produced tumours of the forestomach in mice and mammary gland, lung and other tumours in rats. Two dogs given NFTA orally developed tumours.

5.2 Human carcinogenicity data

The major source of exposure is its use in therapeutics. There is no information on the long-term effects of NFTA in humans.

Subsequent evaluations: Vol. 7 (1974); Suppl. 7 (1987) (p. 67: Group 2B)

For definition of Groups, see Preamble Evaluation.

Last updated: 16 March 1998





























    See Also:
       Toxicological Abbreviations
       N-[4-(5-Nitro-2-Furyl)-2-Thiazolyl]Acetamide (IARC Summary & Evaluation, Volume 7, 1974)